Implantica AG (STU:8IM1) Interest Coverage: 0 (At Loss) (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:8IM1 Implantica AG STU:8IM1
36 GF Score
Price €5.60
View Full Analysis

What is Implantica AG Interest Coverage?

Implantica AG STU:8IM1 +1.82% 36 Interest Coverage is 0 (At Loss) as of . 20. GuruFocus rates STU:8IM1 with a GF Score™ of 36/100. Among 463 Medical Devices & Instruments companies, Implantica AG ranks worse than 215982.51% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Implantica AG's Operating Income for the six months ended in . 20 was €0.00 Mil. Implantica AG's Interest Expense for the six months ended in . 20 was €0.00 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Implantica AG's Interest Coverage or its related term are showing as below:


STU:8IM1's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.24
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Implantica AG  (STU:8IM1) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Implantica AG Interest Coverage Related Terms


Implantica AG Interest Coverage Historical Data

* Premium members only.

The historical data trend for Implantica AG's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Implantica AG Interest Coverage Chart

Implantica AG Annual Data
Trend
Interest Coverage

Implantica AG Semi-Annual Data
Interest Coverage

STU:8IM1 vs : Interest Coverage Comparison

For the Medical Devices subindustry, Implantica AG's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Implantica AG Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Implantica AG's Interest Coverage falls into.


STU:8IM1
36GF Score
Implantica AG STU:8IM1
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implantica AG Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Implantica AG's Interest Coverage for the fiscal year that ended in . 20 is calculated as

Here, for the fiscal year that ended in . 20, Implantica AG's Interest Expense was €0.00 Mil. Its Operating Income was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

Implantica AG had no debt (1).

Implantica AG's Interest Coverage for the quarter that ended in . 20 is calculated as

Here, for the six months ended in . 20, Implantica AG's Interest Expense was €0.00 Mil. Its Operating Income was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation was €0.00 Mil.

Implantica AG had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 0 (At Loss) mean?
Implantica AG (STU:8IM1) has a Interest Coverage of 0 (At Loss) as of . 20. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 463 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Interest Coverage too high?
Implantica AG's current Interest Coverage is 0 (At Loss). Based on the distribution chart, Implantica AG ranks #999999 out of 463 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Interest Coverage compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 463 companies for Interest Coverage. This places Implantica AG in the lower half of its industry. The industry median Interest Coverage is 16.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.24, based on 463 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Interest Coverage is 0 (At Loss). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (STU:8IM1) has a current Interest Coverage of 0 (At Loss). The current Interest Coverage is 0 (At Loss). Implantica AG's overall GF Score™ is 36/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Implantica AG (STU:8IM1), the current Interest Coverage is 0 (At Loss) as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Other Exchanges IMP A SDB:Sweden
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
36GF Score

Get the complete analysis for STU:8IM1

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.60
Price